vs
Forafric Global PLC（AFRI）与Amphastar Pharmaceuticals, Inc.（AMPH）财务数据对比。点击上方公司名可切换其他公司
Amphastar Pharmaceuticals, Inc.的季度营收约是Forafric Global PLC的1.1倍（$183.1M vs $159.7M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs -7.5%，领先20.9%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $146.0K）
Forafric Global PLC是一家聚焦非洲市场的农业综合企业，业务覆盖农产品生产、加工、分销全价值链，主营谷物、植物油等主食产品，核心市场为北非和西非地区，服务多领域客户，助力区域粮食安全保障。
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
AFRI vs AMPH — 直观对比
营收规模更大
AMPH
是对方的1.1倍
$159.7M
净利率更高
AMPH
高出20.9%
-7.5%
自由现金流更多
AMPH
多$24.4M
$146.0K
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $159.7M | $183.1M |
| 净利润 | $-12.0M | $24.4M |
| 毛利率 | 10.7% | 46.8% |
| 营业利润率 | -2.5% | 19.4% |
| 净利率 | -7.5% | 13.3% |
| 营收同比 | — | -1.8% |
| 净利润同比 | — | -35.7% |
| 每股收益（稀释后） | — | $0.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AFRIAMPH
| Q4 25 | — | $183.1M | ||
| Q3 25 | — | $191.8M | ||
| Q2 25 | $159.7M | $174.4M | ||
| Q1 25 | — | $170.5M | ||
| Q4 24 | — | $186.5M | ||
| Q3 24 | — | $191.2M | ||
| Q2 24 | $145.6M | $182.4M | ||
| Q1 24 | — | $171.8M |
净利润AFRIAMPH
| Q4 25 | — | $24.4M | ||
| Q3 25 | — | $17.4M | ||
| Q2 25 | $-12.0M | $31.0M | ||
| Q1 25 | — | $25.3M | ||
| Q4 24 | — | $38.0M | ||
| Q3 24 | — | $40.4M | ||
| Q2 24 | $-8.6M | $37.9M | ||
| Q1 24 | — | $43.2M |
毛利率AFRIAMPH
| Q4 25 | — | 46.8% | ||
| Q3 25 | — | 51.4% | ||
| Q2 25 | 10.7% | 49.6% | ||
| Q1 25 | — | 50.0% | ||
| Q4 24 | — | 46.5% | ||
| Q3 24 | — | 53.3% | ||
| Q2 24 | 9.4% | 52.2% | ||
| Q1 24 | — | 52.4% |
营业利润率AFRIAMPH
| Q4 25 | — | 19.4% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | -2.5% | 24.2% | ||
| Q1 25 | — | 21.9% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 29.8% | ||
| Q2 24 | -0.9% | 30.3% | ||
| Q1 24 | — | 27.9% |
净利率AFRIAMPH
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | -7.5% | 17.8% | ||
| Q1 25 | — | 14.8% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | — | 21.1% | ||
| Q2 24 | -5.9% | 20.8% | ||
| Q1 24 | — | 25.1% |
每股收益（稀释后）AFRIAMPH
| Q4 25 | — | $0.51 | ||
| Q3 25 | — | $0.37 | ||
| Q2 25 | — | $0.64 | ||
| Q1 25 | — | $0.51 | ||
| Q4 24 | — | $0.74 | ||
| Q3 24 | — | $0.78 | ||
| Q2 24 | — | $0.73 | ||
| Q1 24 | — | $0.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.2M | $282.8M |
| 总债务越低越好 | — | $608.7M |
| 股东权益账面价值 | $5.3M | $788.8M |
| 总资产 | $246.1M | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.77× |
8季度趋势，按日历期对齐
现金及短期投资AFRIAMPH
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $276.2M | ||
| Q2 25 | $12.2M | $231.8M | ||
| Q1 25 | — | $236.9M | ||
| Q4 24 | — | $221.6M | ||
| Q3 24 | — | $250.5M | ||
| Q2 24 | $16.4M | $217.8M | ||
| Q1 24 | — | $289.6M |
总债务AFRIAMPH
| Q4 25 | — | $608.7M | ||
| Q3 25 | — | $608.6M | ||
| Q2 25 | — | $607.7M | ||
| Q1 25 | — | $603.9M | ||
| Q4 24 | — | $601.6M | ||
| Q3 24 | — | $596.4M | ||
| Q2 24 | $18.4M | $586.9M | ||
| Q1 24 | — | $594.0M |
股东权益AFRIAMPH
| Q4 25 | — | $788.8M | ||
| Q3 25 | — | $776.7M | ||
| Q2 25 | $5.3M | $757.5M | ||
| Q1 25 | — | $751.3M | ||
| Q4 24 | — | $732.3M | ||
| Q3 24 | — | $727.7M | ||
| Q2 24 | $16.3M | $713.3M | ||
| Q1 24 | — | $672.4M |
总资产AFRIAMPH
| Q4 25 | — | $1.6B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $246.1M | $1.6B | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $287.1M | $1.5B | ||
| Q1 24 | — | $1.6B |
负债/权益比AFRIAMPH
| Q4 25 | — | 0.77× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 0.80× | ||
| Q4 24 | — | 0.82× | ||
| Q3 24 | — | 0.82× | ||
| Q2 24 | 1.13× | 0.82× | ||
| Q1 24 | — | 0.88× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $706.0K | $32.9M |
| 自由现金流经营现金流 - 资本支出 | $146.0K | $24.6M |
| 自由现金流率自由现金流/营收 | 0.1% | 13.4% |
| 资本支出强度资本支出/营收 | 0.4% | 4.5% |
| 现金转化率经营现金流/净利润 | — | 1.35× |
| 过去12个月自由现金流最近4个季度 | — | $121.2M |
8季度趋势，按日历期对齐
经营现金流AFRIAMPH
| Q4 25 | — | $32.9M | ||
| Q3 25 | — | $52.6M | ||
| Q2 25 | $706.0K | $35.6M | ||
| Q1 25 | — | $35.1M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | $10.5M | $69.1M | ||
| Q1 24 | — | $55.3M |
自由现金流AFRIAMPH
| Q4 25 | — | $24.6M | ||
| Q3 25 | — | $47.2M | ||
| Q2 25 | $146.0K | $25.0M | ||
| Q1 25 | — | $24.4M | ||
| Q4 24 | — | $16.6M | ||
| Q3 24 | — | $46.2M | ||
| Q2 24 | $6.4M | $63.1M | ||
| Q1 24 | — | $46.5M |
自由现金流率AFRIAMPH
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 24.6% | ||
| Q2 25 | 0.1% | 14.3% | ||
| Q1 25 | — | 14.3% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 24.1% | ||
| Q2 24 | 4.4% | 34.6% | ||
| Q1 24 | — | 27.1% |
资本支出强度AFRIAMPH
| Q4 25 | — | 4.5% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | 0.4% | 6.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | 2.8% | 3.3% | ||
| Q1 24 | — | 5.1% |
现金转化率AFRIAMPH
| Q4 25 | — | 1.35× | ||
| Q3 25 | — | 3.03× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.39× | ||
| Q4 24 | — | 0.76× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 1.82× | ||
| Q1 24 | — | 1.28× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AFRI
| Sales to external customers, Total | $159.7M | 100% |
| Couscous & Pasta | $934.0K | 1% |
| Soft Wheat | $393.0K | 0% |
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
